CN116693531A - Synthesis method of bridged polycyclic lactam compound - Google Patents

Synthesis method of bridged polycyclic lactam compound Download PDF

Info

Publication number
CN116693531A
CN116693531A CN202310681131.XA CN202310681131A CN116693531A CN 116693531 A CN116693531 A CN 116693531A CN 202310681131 A CN202310681131 A CN 202310681131A CN 116693531 A CN116693531 A CN 116693531A
Authority
CN
China
Prior art keywords
reaction
bridged polycyclic
lactam compound
oxo
ethyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202310681131.XA
Other languages
Chinese (zh)
Inventor
张志国
史兵兵
张贵生
蓝宇
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Henan Normal University
Original Assignee
Henan Normal University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Henan Normal University filed Critical Henan Normal University
Priority to CN202310681131.XA priority Critical patent/CN116693531A/en
Publication of CN116693531A publication Critical patent/CN116693531A/en
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/08Bridged systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

The invention relates to a method for synthesizing a bridged polycyclic lactam compound, which belongs to the technical field of organic synthesis. The synthesis method has the characteristics of green, simplicity, effectiveness and high selectivity, is carried out under the metal-free condition, and can obtain the bridged polycyclic lactam compound through one-step reaction, so that the substrate is low in cost, the steps are simple, and the operation is easy.

Description

Synthesis method of bridged polycyclic lactam compound
Technical Field
The invention belongs to the technical field of organic synthesis, and particularly relates to a synthesis method of a bridged polycyclic lactam compound.
Background
Nitrogen-containing bridged ring systems are present in a variety of biologically important molecules, which have attracted considerable attention in the past decades by organic and bioorganic chemists as important components of a variety of natural products and pharmaceutical agents. Bridged bicyclic lactams, in particular comprising a lactam nitrogen at the bridgehead position, have been of interest for many years because they comprise distorted amides which fail to achieve standard planar geometries. The distorted amide moiety embedded in the bridge ring causes rapid hydrolysis of these amides. Thus, standard methods for amide synthesis of these compounds typically proceed in low yields or with difficulties in product isolation. Under such circumstances, various synthetic methods have been explored which avoid the direct use of amide bond formation as a key reaction step. However, most of these reactions require pre-functionalized starting materials, cumbersome procedures and demanding reaction conditions. Thus, it is highly desirable, but challenging, to be able to efficiently transfer readily available acyclic substrates to such bridged polycyclic lactams.
At present, there are reports of synthetic methods of bridged polycyclic lactam derivatives, and from the viewpoint of synthetic strategies, these methods can be classified into three categories:
the first is the rapid acquisition of lactams by intramolecular hydrocarbonylation of olefins, however, selective carbonylation with lactam nitrogen at the bridgehead position to form bridged polycyclic lactams has been less studied. A modular palladium catalyzed process is reported to perform an Alder cycloaddition reaction of a series of hydrocarbylated lactams/Diels-with 2-vinylarylaldehyde imines, olefins and CO, providing a convenient route to bridging polycyclic lactams in high selectivity and yield, such as literature: P.Xu, B.Qian, B.Hu, H, huang. Org Lett,2022,24,147-151.
The second category is palladium-catalyzed aza-packer cyclisation to form bridged lactams by formation of C-N bonds, such as literature: C.Xie, J.Luo, Y.Zhang, S-H.H, L.Zhu, R.Hong.Org Lett,2018,20,2386-2390.
The third category is the problem of the cationic-pi controlled intramolecular schmitt reaction to form bridged bicyclic lactams, the reaction promoted by the acid of the alkyl azide and ketone to synthesize bridged bicyclic lactams, where regiochemistry is controlled by the trans-steric interaction of the key reaction intermediate aryl and the cationic leaving group, such as in documents L.Yao, J.Aube.J.Am.Chem.Soc.2007,129,2766-2767.
Bridged polycyclic lactams are special motifs that are ubiquitous in natural products, pharmaceuticals and agrochemicals. The importance of bridged polycyclic lactam compounds can be found in chemical disciplines, and with the use of drugs/bioactivity studies, polymerization studies, etc., as well as a basis for larger, more complex organic molecules, the need for new ways to obtain these ideal molecules is expanding. Although the synthesis of bridged polycyclic lactam compounds has been reported in the literature, the problems are also apparent, and thus the development of a greener, simple and efficient method for synthesizing bridged bicyclic lactam compounds is still of great practical significance.
Disclosure of Invention
In order to solve the technical problems, the invention provides a synthesis method of a bridged polycyclic lactam compound, which has the characteristics of green, simplicity, effectiveness and high selectivity, is carried out under the condition of no metal, and can obtain the bridged polycyclic lactam compound through one-step reaction, and has the advantages of low substrate cost, simple steps and easy operation.
The invention provides a method for synthesizing bridged polycyclic lactam compound, which takes 3-oxo-3- (phenylamino) ethyl propionate compounds and methyl styryl ketone as raw materials and potassium tert-butoxide t BuOK) provides an alkaline environment and uses ethanol (EtOH) as a solvent to synthesize the bridged polycyclic lactam compound in one step.
The synthesis method disclosed by the invention has the advantages of simple reaction conditions, effective method, wide application range and green economy, not only can further enrich the synthesis method of the bridged polycyclic lactam compound, but also provides more candidate methods for industrial screening.
Preferably, the molar ratio of the 3-oxo-3- (phenylamino) propionic acid ethyl ester compound to the benzine is 1:2.2, for example, the molar number of the 3-oxo-3- (phenylamino) propionic acid ethyl ester compound may be 0.3mmol, and the molar number of the benzine is 0.66mmol.
Preferably, the structural formula of the 3-oxo-3- (phenylamino) propionic acid ethyl ester compound is as follows:
the substituent R is selected from-4-Me, -4-OMe, -3-Me, -2-Me, -H, -4-Cl, -3-Cl or-4-CO 2 Et。
Preferably, the reaction is carried out under air conditions.
Preferably, the reaction temperature is 60℃and the reaction is carried out with stirring.
Preferably, the method further comprises the step of removing the solvent by reduced pressure evaporation after the reaction is finished, and separating by column chromatography to obtain the bridged polycyclic lactam compound.
Preferably, the bridged polycyclic lactam compound of the present invention is synthesized as follows:
the substituent R is selected from-4-Me, -4-OMe, -3-Me, -2-Me, -H, -4-Cl, -3-Cl or-4-CO 2 Et。
In the synthetic method of the present invention, the reaction step requires only one step. The ethyl 3-oxo-3- (phenylamino) propionate compound and the methyl styrene ketone are all easy-to-obtain chemicals, and preferably when 2.2 equivalents of methyl styrene ketone, 4.0 equivalents of potassium tert-butoxide and 3mL of ethanol are used, the bridged polycyclic lactam compound is generated.
Compared with the prior art, the invention has the following advantages and technical effects:
the synthesis method has the advantages of few steps, low raw material cost, easy acquisition, low technical difficulty and easy operation. The synthesis method avoids the process of using multi-step reaction and the use of metal catalysts, and the target product can be obtained only by evaporating the solvent under reduced pressure after the reaction is finished and separating the solvent by column chromatography.
Detailed Description
Various exemplary embodiments of the invention will now be described in detail, which should not be considered as limiting the invention, but rather as more detailed descriptions of certain aspects, features and embodiments of the invention.
It is to be understood that the terminology used herein is for the purpose of describing particular embodiments only and is not intended to be limiting of the invention. In addition, for numerical ranges in this disclosure, it is understood that each intermediate value between the upper and lower limits of the ranges is also specifically disclosed. Every smaller range between any stated value or stated range, and any other stated value or intermediate value within the stated range, is also encompassed within the invention. The upper and lower limits of these smaller ranges may independently be included or excluded in the range.
Unless otherwise defined, all technical and scientific terms used herein have the same meaning as commonly understood by one of ordinary skill in the art to which this invention belongs. Although only preferred methods and materials are described herein, any methods and materials similar or equivalent to those described herein can be used in the practice or testing of the present invention. All documents mentioned in this specification are incorporated by reference for the purpose of disclosing and describing the methods and/or materials associated with the documents. In case of conflict with any incorporated document, the present specification will control.
It will be apparent to those skilled in the art that various modifications and variations can be made in the specific embodiments of the invention described herein without departing from the scope or spirit of the invention. Other embodiments will be apparent to those skilled in the art from consideration of the specification of the present invention. The specification and examples of the present invention are exemplary only.
As used herein, the terms "comprising," "including," "having," "containing," and the like are intended to be inclusive and mean an inclusion, but not limited to.
Example 1
Ethyl 3-oxo-3- (p-tolylamino) propionate (66 mg,0.3 mmol), methyl styrene ketone (154 mg,0.66 mmol), potassium tert-butoxide (135 mg,1.2 mmol) and 3mL of ethanol are added into a 15mL pressure-resistant tube, the mixture is stirred for 1 hour at 60 ℃ under the air condition, TCL is used for monitoring the reaction process, the solvent is removed by reduced pressure evaporation after the reaction is finished, and the white solid is obtained after column chromatography separation: 146mg, 71% yield.
White solid, yield 71%. 1 H NMR(400MHz,CDCl 3 )δ7.46(d,J=8.0Hz,2H),7.34(d,J=8.0Hz,2H),7.29(d,J=6.8Hz,2H),7.25–7.14(m,12H),7.09(d,J=7.2Hz,1H),6.97–6.95(m,3H),6.80–6.73(m,3H),6.29(s,1H),6.13(d,J=16.4Hz,1H),3.94(d,J=13.2Hz,1H),3.34(d,J=5.2Hz,1H),3.26(d,J=4.8Hz,1H),3.01(s,3H),2.96(d,J=12.0Hz,2H),2.77(s,1H),2.47(s,1H),2.44(s,1H),2.18(d,J=11.2Hz,1H). 13 C NMR(151MHz,CDCl 3 )δ169.6,165.5,141.3,141.1,140.5,137.3,135.7,133.2,132.9,130.7,129.4,129.1,128.9,128.6,128.6,128.3,128.2,128.0,128.0,127.4,127.3,126.7,126.6,126.5,87.5,60.7,55.5,55.3,51.4,51.3,48.5,35.5,30.2,21.3.
Example 2
Ethyl 3- ((4-methoxyphenyl) amino) -3-oxopropionate (71 mg,0.3 mmol), methyl styryl ketone (154 mg,0.66 mmol), potassium tert-butoxide (135 mg,1.2 mmol) and 3mL of ethanol are added into a 15mL pressure-resistant tube, the mixture is stirred for 1 hour at 60 ℃ under the air condition, the reaction process is monitored by using TCL, the solvent is removed under reduced pressure after the reaction is finished, and the white solid is obtained after column chromatography separation: 106mg, 50% yield.
White solid, yield 50%. 1 H NMR(600MHz,CDCl 3 )δ7.47(d,J=9.0Hz,2H),7.30–7.27(m,3H),7.24(d,J=7.8Hz,2H),7.22–7.20(m,2H),7.18–7.14(m,7H),7.09(d,J=7.2Hz,1H),7.05(d,J=9.0Hz,2H),6.93–6.91(m,3H),6.76–6.75(m,2H),6.72(d,J=16.2Hz,1H),6.32(s,1H),6.11(d,J=16.2Hz,1H),3.90(d,J=12.6Hz,1H),3.87(s,3H),3.46(q,J=7.2Hz,2H),3.31(d,J=4.8Hz,1H),3.23(d,J=5.4Hz,1H),2.97–2.92(m,2H),2.70(d,J=5.4Hz,2H),2.17–2.14(m,1H),0.45(t,J=13.2Hz,3H). 13 C NMR(151MHz,CDCl 3 )δ169.3,165.9,158.7,141.5,141.3,140.6,135.8,132.9,130.6,130.1,129.3,128.6,128.3,128.2,127.9,127.4,127.3,126.8,126.6,126.4,114.2,87.5,60.6,60.2,55.8,55.5,55.5,51.3,48.5,35.5,30.1 13.1.
Example 3
Ethyl 3-oxo-3- (m-tolylamino) propionate (66 mg,0.3 mmol), methyl styrene ketone (154 mg,0.66 mmol), potassium tert-butoxide (135 mg,1.2 mmol) and 3mL of ethanol are added into a 15mL pressure-resistant tube, the mixture is stirred for 1 hour at 60 ℃ under the air condition, the reaction process is monitored by using TCL, the solvent is removed by reduced pressure evaporation after the reaction is finished, and the white solid is obtained after column chromatography separation: 93mg, 45% yield.
White solid, yield: 45%. 1 H NMR(400MHz,CDCl 3 )δ7.40(t,J=8.4Hz,1H),7.34(d,J=6.8Hz,2H),7.30–7.27(m,2H),7.24–7.20(m,5H),7.18–7.12(m,7H),7.09(t,J=7.2Hz,1H),6.94–6.90(m,3H),6.78–6.76(m,2H),6.70(d,J=16.0Hz,1H),6.39(s,1H),6.09(d,J=16.0Hz,1H),3.91–3.87(m,1H),3.45(q,J=7.2Hz,2H),3.31(d,J=4.8Hz,1H),3.23(d,J=5.2Hz,1H),2.94–2.88(m,3H),2.72(d,J=2.8Hz,1H),2.46(s,3H),2.13(dd,J=14.4,5.4Hz,1H),0.45(t,J=7.2Hz,3H). 13 C NMR(101MHz,CDCl 3 )δ169.3,165.7,141.5,141.3,140.6,138.6,135.9,135.8,132.9,130.7,129.9,129.3,128.6,128.5,128.3,128.2,127.9,127.4,127.3,126.8,126.6,126.4,126.2,87.6,60.6,60.2,55.8,55.6,51.4,48.6,35.5,30.1,21.6,13.1.
Example 4
Ethyl 3-oxo-3- (o-tolylamino) propionate (66 mg,0.3 mmol), methyl styrene ketone (154 mg,0.66 mmol), potassium tert-butoxide (135 mg,1.2 mmol) and 3mL of ethanol are added into a 15mL pressure-resistant tube, the mixture is stirred for 1 hour at 60 ℃ under the air condition, the reaction process is monitored by using TCL, the solvent is removed by reduced pressure evaporation after the reaction is finished, and the white solid is obtained after column chromatography separation: 116mg, 56% yield.
White solid, yield: 56%. 1 H NMR(400MHz,DMSO)δ7.65(d,J=56.8Hz,1H),7.42–7.39(m,3H),7.37–7.30(m,8H),7.28–7.19(m,3H),7.15(d,J=7.2Hz,3H),7.03–6.79(m,4H),6.64(dd,J=11.6,8.0Hz,2H),6.44–6.31(m,2H),3.86–3.77(m,1H),3.55–3.51(m,1H),3.48–3.38(m,3H),3.33(s,1H),3.13(t,J=14.0Hz,1H),2.77(d,J=14.0Hz,1H),2.50(s,3H),2.32(s,1H),1.95–1.89(m,1H),0.52–0.46(m,3H). 13 C NMR(101MHz,DMSO)δ168.3,168.1,166.7,166.0,142.6,142.3,142.2,142.0,141.9,138.5,138.4,137.2,137.1,137.0,135.3,135.2,131.3,131.2,129.8,129.6,128.9,128.9,128.8,128.7,128.5,128.4,128.3,128.2,128.0,127.8,127.3,127.0,126.9,126.8,88.2,76.2,75.9,60.0,59.1,58.9,55.9,55.7,51.6,50.7,48.9,47.5,35.9,20.8,13.6.
Example 5
Ethyl 3-oxo-3- (phenylamino) propionate (62 mg,0.3 mmol), benzine (154 mg,0.66 mmol), potassium tert-butoxide (135 mg,1.2 mmol) and 3mL of ethanol are added into a 15mL pressure-resistant tube, the reaction process is monitored by TCL under the condition of air and is stirred for 1 hour at 60 ℃, the solvent is removed by reduced pressure evaporation after the reaction is finished, and the white solid is obtained after column chromatography separation: 119mg, 59% yield.
White solid, yield 59%. 1 H NMR(400MHz,CDCl 3 )δ7.56–7.50(m,4H),7.40(dd,J=6.8,1.6Hz,1H),7.32–7.28(m,3H),7.23–7.20(m,4H),7.17–7.13(m,6H),7.08(t,J=6.8Hz,1H),6.94–6.90(m,3H),6.76(dd,J=7.2,1.6Hz,1H),6.70(d,J=16.0Hz,1H),6.43(s,1H),6.08(d,J=16.4Hz,1H),3.91–3.88(m,1H),3.45(q,J=7.2Hz,2H),3.31(d,J=5.2Hz,1H),3.23(d,J=4.8Hz,1H),2.95–2.92(m,2H),2.88(s,1H),2.73(d,J=4.8Hz,1H),2.14(dd,J=14.0,3.6Hz,1H),0.45(t,J=6.8Hz,3H). 13 C NMR(101MHz,CDCl 3 )δ169.3,165.7,141.4,141.2,140.5,136.0,135.7,132.9,130.7,129.3,129.2,128.7,128.6,128.3,128.2,127.9,127.5,127.4,127.3,126.8,126.6,126.4,87.6,60.6,60.2,55.8,55.6,51.3,48.5,35.5,30.1,13.1.
Example 6
Ethyl 3- ((4-chlorophenyl) amino) -3-oxopropionate (72 mg,0.3 mmol), methyl styryl ketone (154 mg,0.66 mmol), potassium tert-butoxide (135 mg,1.2 mmol) and 3mL of ethanol are added into a 15mL pressure-resistant tube, the mixture is stirred for 1 hour at 60 ℃ under the condition of air, the reaction process is monitored by using TCL, the solvent is removed by reduced pressure evaporation after the reaction, and the mixture is separated by column chromatography to obtain white solid: 125mg, 59% yield.
White solid, yield: 59%. 1 H NMR(400MHz,CDCl 3 )δ7.52–7.49(m,4H),7.30(d,J=6.4Hz,3H),7.24(d,J=7.2Hz,2H),7.18–7.16(m,9H),7.10(d,J=6.8Hz,1H),6.94(d,J=6.0Hz,3H),6.76–6.72(m,3H),6.49(s,1H),6.10(d,J=16.4Hz,1H),3.92(d,J=13.2Hz,1H),3.48(q,J=7.2Hz,2H),3.32(d,J=4.8Hz,1H),3.25(d,J=5.2Hz,1H),2.99–2.92(m,2H),2.73(s,1H),2.51(s,1H),2.17(d,J=14.0Hz,1H),0.47(t,J=6.8Hz,3H). 13 C NMR(151MHz,CDCl 3 )δ169.0,165.8,141.2,141.0,140.4,135.7,134.4,133.1,132.7,130.8,130.5,129.2,128.8,128.6,128.4,128.3,128.1,128.0,127.4,127.3,126.7,126.6,126.5,87.7,60.7,60.1,55.7,55.4,51.2,48.5,35.5,30.0,13.2.
Example 7
Ethyl 3- ((3-chlorophenyl) amino) -3-oxopropionate (72 mg,0.3 mmol), methyl styryl ketone (154 mg,0.66 mmol), potassium tert-butoxide (135 mg,1.2 mmol) and 3mL of ethanol are added into a 15mL pressure-resistant tube, the mixture is stirred for 1 hour at 60 ℃ under the condition of air, the reaction process is monitored by using TCL, the solvent is removed by reduced pressure evaporation after the reaction, and the mixture is separated by column chromatography to obtain white solid: 123mg, 58% yield.
White solid, yield: 58%. 1 H NMR(400MHz,CDCl 3 )δ7.57(s,1H),7.49–7.48(m,1H),7.45(d,J=8.0Hz,1H),7.39(d,J=7.6Hz,1H),7.31–7.27(m,1H),7.25–7.24(m,1H),7.19–7.15(m,9H),7.10(t,J=5.6Hz,1H),6.96–6.95(m,3H),6.78–6.74(m,3H),6.48(s,1H),6.12(d,J=16.4Hz,1H),3.94(d,J=13.2Hz,1H),3.50(q,J=6.8Hz,2H),3.34(d,J=5.2Hz,1H),3.26(d,J=4.8Hz,1H),3.02–2.95(m,2H),2.75(s,1H),2.41(s,1H),2.18(d,J=10.8Hz,1H),0.48(t,J=7.2Hz,3H). 13 C NMR(151MHz,CDCl 3 )δ169.0,165.6,141.1,140.9,140.3,137.0,135.6,134.0,132.6,130.9,129.5,129.4,129.2,128.6,128.6,128.4,128.3,128.0 127.9,127.6,127.5,127.4,127.3,126.7,126.6,126.5,87.8,60.7,60.2,55.6,55.4,51.2,48.4,35.5,30.1,13.1.
Example 8
Ethyl 4- (3-ethoxy-3-oxopropanamido) benzoate (84 mg,0.3 mmol), methyl styryl ketone (154 mg,0.66 mmol), potassium tert-butoxide (135 mg,1.2 mmol) and 3mL of ethanol are added into a 15mL pressure-resistant pipe, the mixture is stirred for 1 hour at 60 ℃ under the air condition, TCL is used for monitoring the reaction process, the solvent is removed by reduced pressure evaporation after the reaction is finished, and the white solid is obtained after column chromatography separation: 110mg, 61% yield.
White solid, yield: 61%. 1 H NMR(600MHz,CDCl3)δ8.19(d,J=8.4Hz,2H),7.63(d,J=8.4Hz,2H),7.29(d,J=7.2Hz,2H),7.24(d,J=7.2Hz,2H),7.18–7.15(m,8H),7.10(d,J=7.2Hz,2H),6.94(d,J=7.8Hz,3H),6.75(d,J=5.4Hz,3H),6.55(s,1H),6.11(d,J=16.2Hz,1H),4.42(dd,J=14.4,7.2Hz,2H),3.93(d,J=12.6Hz,1H),3.48–3.47(m,2H),3.34(d,J=5.4Hz,1H),3.27(d,J=4.2Hz,1H),2.97–2.93(m,2H),2.77(s,1H),2.69(s,1H),2.18(d,J=13.8Hz,1H),1.42(t,J=6.6Hz,2H),0.47(t,J=7.2Hz,2H). 13 C NMR(151MHz,CDCl3)δ191.9,170.0,167.2,135.8,132.8,130.8,129.9,129.2,129.2,129.1,128.6,128.3,128.1,128.0,127.5,127.4,126.8,126.7,126.6,88.0,61.2,60.8,60.3,55.7,55.4,51.2,48.6,35.8,30.1,14.4,13.2,10.8.
The present invention is not limited to the above-mentioned embodiments, and any changes or substitutions that can be easily understood by those skilled in the art within the technical scope of the present invention are intended to be included in the scope of the present invention. Therefore, the protection scope of the present invention should be subject to the protection scope of the claims.

Claims (6)

1. A method for synthesizing a bridged polycyclic lactam compound is characterized in that 3-oxo-3- (phenylamino) ethyl propionate compounds and methyl styrene ketone are used as raw materials, potassium tert-butoxide is used for providing an alkaline environment, ethanol is used as a solvent, and the bridged polycyclic lactam compound is synthesized in one step.
2. The method according to claim 1, wherein the molar ratio of the ethyl 3-oxo-3- (phenylamino) propionate to the benzine is 1:2.2.
3. The synthetic method according to claim 2, wherein the ethyl 3-oxo-3- (phenylamino) propionate compound has the following structural formula:
the substituent R is selected from-4-Me, -4-OMe, -3-Me, -2-Me, -H, -4-Cl, -3-Cl or-4-CO 2 Et。
4. The synthetic method of claim 1 wherein the reaction is carried out under air conditions.
5. The synthesis according to claim 1, wherein the reaction temperature is 60 ℃, and the reaction is carried out under stirring.
6. The method according to claim 1, wherein the reaction further comprises removing the solvent by evaporation under reduced pressure after completion of the reaction, and separating by column chromatography.
CN202310681131.XA 2023-06-09 2023-06-09 Synthesis method of bridged polycyclic lactam compound Pending CN116693531A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202310681131.XA CN116693531A (en) 2023-06-09 2023-06-09 Synthesis method of bridged polycyclic lactam compound

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202310681131.XA CN116693531A (en) 2023-06-09 2023-06-09 Synthesis method of bridged polycyclic lactam compound

Publications (1)

Publication Number Publication Date
CN116693531A true CN116693531A (en) 2023-09-05

Family

ID=87835286

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202310681131.XA Pending CN116693531A (en) 2023-06-09 2023-06-09 Synthesis method of bridged polycyclic lactam compound

Country Status (1)

Country Link
CN (1) CN116693531A (en)

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5525723A (en) * 1993-11-18 1996-06-11 Bristol-Myers Squibb Co. Compounds containing a fused multiple ring lactam
CN104364254A (en) * 2012-04-02 2015-02-18 阿斯利康(瑞典)有限公司 Heterobicyclic compounds as beta-lactamase inhibitors
US20170002003A1 (en) * 2014-01-24 2017-01-05 Max-Planck-Gesellschaft Zur Forderung Der Wissensc Haften E.V. Diazabicyclo[4.3.1]decane derivatives for treatment of psychiatric disorders
CN109715630A (en) * 2016-09-16 2019-05-03 恩塔西斯治疗有限公司 Beta-lactamase inhibitor compound
CN114075196A (en) * 2020-08-21 2022-02-22 上海凌达生物医药有限公司 Aromatic ring-lactam compound, preparation method and application thereof
CN114195671A (en) * 2021-12-27 2022-03-18 河南师范大学 Asymmetric malonanilide compound and synthesis method thereof

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5525723A (en) * 1993-11-18 1996-06-11 Bristol-Myers Squibb Co. Compounds containing a fused multiple ring lactam
CN104364254A (en) * 2012-04-02 2015-02-18 阿斯利康(瑞典)有限公司 Heterobicyclic compounds as beta-lactamase inhibitors
US20170002003A1 (en) * 2014-01-24 2017-01-05 Max-Planck-Gesellschaft Zur Forderung Der Wissensc Haften E.V. Diazabicyclo[4.3.1]decane derivatives for treatment of psychiatric disorders
CN109715630A (en) * 2016-09-16 2019-05-03 恩塔西斯治疗有限公司 Beta-lactamase inhibitor compound
CN114075196A (en) * 2020-08-21 2022-02-22 上海凌达生物医药有限公司 Aromatic ring-lactam compound, preparation method and application thereof
CN114195671A (en) * 2021-12-27 2022-03-18 河南师范大学 Asymmetric malonanilide compound and synthesis method thereof

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
BINGBING SHI ET AL.: "Anion Cascade Reactions II: Synthesis of 3‑Isoquinuclidone-Based Bridged Polycyclic Lactams", 《ORG. LETT.》, vol. 25, 8 September 2023 (2023-09-08), pages 6846 *

Similar Documents

Publication Publication Date Title
Song et al. Practical asymmetric synthesis of an endothelin receptor antagonist
Li et al. Polyisobutylene supports—a non-polar hydrocarbon analog of PEG supports
US5744642A (en) Process for the preparation of aliphatic imines
JP2002507222A (en) Method for producing substituted perhydroisoindole
CN104961640B (en) A kind of preparation method of optically pure 3-amino-n-butyl alcohol
CN113200933B (en) Method for synthesizing optically active benzocarboxylate compound by asymmetric addition reaction
CN116693530A (en) Synthesis method of bridged dicyclolactam compound
CN116693531A (en) Synthesis method of bridged polycyclic lactam compound
EP2914574A2 (en) New process
Okada et al. Generation and cycloaddition of polymer-supported azomethine ylide by utilizing the characteristics of silicon: a facile route to pyrrolidines and pyrroles from α-silylimines bound to resin
CN108276284A (en) Method for preparing α -unsaturated carboxylic ester derivative by visible light catalysis
CN111233745A (en) (E)1- (9-alkyl-carbazole-3-) -acrylic acid and preparation method thereof
Bates et al. Synthesis of N, O-heterocycles by intramolecular conjugate addition of a hydroxylamine
CN115246786B (en) Preparation method of indole compound or benzoxazine compound
CN109721590B (en) Method for preparing C2 alpha acyloxy indole by cobalt catalysis
CN115232051B (en) Method for preparing N-substituted indole derivative
Correa et al. Metal-Catalyzed C (sp 2)–N Bond Formation
CN115025814B (en) Universal chiral catalyst and preparation method thereof
CN115028597B (en) Method for preparing benzoxazole derivative by TEMPO continuous dehydrocyclization and application
KR102590897B1 (en) Method for producing chiral gamma-lactam compound and metal complex therefor
CN110590631B (en) Synthetic method of 2, 2-bis-sulfonyl-2H-aziridine
JP4332622B2 (en) Process for producing six-membered ring lactones
CN116693529A (en) Synthesis method of 2-aza [2.2.2] octane compound
Edwards Development of practical in-situ methods for the early transition metal-catalyzed synthesis of amines
Sun et al. Studies on Suzuki coupling reactions of large sterically hindered substrates

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination